Detalhe da pesquisa
1.
HERTHENA-Lung02: phase III study of patritumab deruxtecan in advanced EGFR-mutated NSCLC after a third-generation EGFR TKI.
Future Oncol
; 20(15): 969-980, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38095056
2.
A UK cost-effectiveness analysis of trifluridine/tipiracil for heavily pretreated metastatic gastroesophageal cancers.
Future Oncol
; 19(9): 643-650, 2023 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-37115022
3.
A Bayesian approach for event predictions in clinical trials with time-to-event outcomes.
Stat Med
; 40(28): 6344-6359, 2021 12 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-34541701
4.
Trifluridine/tipiracil plus bevacizumab for third-line management of metastatic colorectal cancer: SUNLIGHT study design.
Future Oncol
; 17(16): 1977-1985, 2021 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-33569986
5.
First-line trifluridine/tipiracil plus bevacizumab for unresectable metastatic colorectal cancer: SOLSTICE study design.
Future Oncol
; 16(4): 21-29, 2020 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-31914811
6.
A nomogram including baseline prognostic factors to estimate the activity of second-line therapy for advanced urothelial carcinoma.
BJU Int
; 113(5b): E137-43, 2014 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-24219029
7.
Trifluridine-tipiracil plus bevacizumab versus capecitabine plus bevacizumab as first-line treatment for patients with metastatic colorectal cancer ineligible for intensive therapy (SOLSTICE): a randomised, open-label phase 3 study.
Lancet Gastroenterol Hepatol
; 8(2): 133-144, 2023 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-36470291
8.
Nomogram to predict the benefit from salvage systemic therapy for advanced urothelial carcinoma.
BJU Int
; 115(6): 854-5, 2015 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-25195625
9.
Phase I dose-escalation of trifluridine/tipiracil in combination with oxaliplatin in patients with metastatic colorectal cancer.
Eur J Cancer
; 112: 12-19, 2019 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-30889492
10.
Cost-effectiveness of Trifluridine/tipiracil for Previously Treated Metastatic Colorectal Cancer in England and Wales.
Clin Colorectal Cancer
; 17(1): e143-e151, 2018 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-29110922
11.
QTWiST analysis of the RECOURSE trial of trifluridine/tipiracil in metastatic colorectal cancer.
ESMO Open
; 2(5): e000284, 2017.
Artigo
em Inglês
| MEDLINE | ID: mdl-29211817
12.
Complete response as an intermediate end point in patients receiving salvage systemic therapy for urothelial carcinoma.
Clin Genitourin Cancer
; 13(2): 185-92, 2015 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-25458370
13.
Six-month progression-free survival as the primary endpoint to evaluate the activity of new agents as second-line therapy for advanced urothelial carcinoma.
Clin Genitourin Cancer
; 12(2): 130-7, 2014 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-24220220
14.
Phase II study of intravenous vinflunine after failure of first-line vinorelbine based regimen for advanced breast cancer.
Breast
; 22(1): 58-63, 2013 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-23195794
15.
Impact of response to prior chemotherapy in patients with advanced urothelial carcinoma receiving second-line therapy: implications for trial design.
Clin Genitourin Cancer
; 11(4): 495-500, 2013 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-23800847
16.
Time from prior chemotherapy enhances prognostic risk grouping in the second-line setting of advanced urothelial carcinoma: a retrospective analysis of pooled, prospective phase 2 trials.
Eur Urol
; 63(4): 717-23, 2013 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-23206856
17.
Prognostic score for second-line chemotherapy of advanced non-small-cell lung cancer: external validation in a phase III trial comparing vinflunine with docetaxel.
Lung Cancer
; 77(1): 116-20, 2012 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-22361218
18.
Optimisation of the size variation threshold for imaging evaluation of response in patients with platinum-refractory advanced transitional cell carcinoma of the urothelium treated with vinflunine.
Eur J Cancer
; 48(10): 1495-502, 2012 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-22176867
19.
Prognostic factors in patients with advanced transitional cell carcinoma of the urothelial tract experiencing treatment failure with platinum-containing regimens.
J Clin Oncol
; 28(11): 1850-5, 2010 Apr 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-20231682
20.
Patient eligibility and trial design for the salvage therapy of advanced urothelial carcinoma.
Clin Genitourin Cancer
; 12(6): 395-8, 2014 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-25035282